Search Results - "MÄKINEN, MARKUS"

Refine Results
  1. 1

    Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance by Tuomisto, Anne E, Mäkinen, Markus J, Väyrynen, Juha P

    Published in World journal of gastroenterology : WJG (21-08-2019)
    “…Systemic inflammation is a marker of poor prognosis preoperatively present in around 20%-40% of colorectal cancer patients. The hallmarks of systemic…”
    Get full text
    Journal Article
  2. 2

    Characteristics and significance of colorectal cancer associated lymphoid reaction by Väyrynen, Juha P., Sajanti, Sara A., Klintrup, Kai, Mäkelä, Jyrki, Herzig, Karl‐Heinz, Karttunen, Tuomo J., Tuomisto, Anne, Mäkinen, Markus J.

    Published in International journal of cancer (01-05-2014)
    “…A subset of colorectal cancers (CRCs) exhibits so‐called Crohn's like lymphoid reaction (CLR), an inflammatory reaction pattern that consists of numerous…”
    Get full text
    Journal Article
  3. 3

    Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer by Sirniö, Päivi, Väyrynen, Juha P., Klintrup, Kai, Mäkelä, Jyrki, Mäkinen, Markus J., Karttunen, Tuomo J., Tuomisto, Anne

    Published in Scientific reports (14-07-2017)
    “…Recent studies have reported of an association between high serum apolipoprotein A1 (APOA1) levels and favorable prognosis in several malignancies, while the…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Endostatin Overexpression Inhibits Lymphangiogenesis and Lymph Node Metastasis in Mice by BRIDEAU, Gaëlle, MÄKINEN, Markus J, ELAMAA, Harri, HONGMIN TU, NILSSON, Gunnar, ALITALO, Kari, PIHLAJANIEMI, Taina, HELJASVAARA, Ritva

    Published in Cancer research (Chicago, Ill.) (15-12-2007)
    “…Endostatin, a proteolytic fragment of collagen XVIII, is a potent inhibitor of angiogenesis and tumor growth. We studied the development of carcinogen-induced…”
    Get full text
    Journal Article
  6. 6

    Prognostic significance of spatial and density analysis of T lymphocytes in colorectal cancer by Elomaa, Hanna, Ahtiainen, Maarit, Väyrynen, Sara A., Ogino, Shuji, Nowak, Jonathan A., Friman, Marjukka, Helminen, Olli, Wirta, Erkki-Ville, Seppälä, Toni T., Böhm, Jan, Mäkinen, Markus J., Mecklin, Jukka-Pekka, Kuopio, Teijo, Väyrynen, Juha P.

    Published in British journal of cancer (01-08-2022)
    “…Background Although high T cell density is a strong favourable prognostic factor in colorectal cancer, the significance of the spatial distribution of T cells…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Immunohistochemical Glucagon-like Peptide-1 Receptor Expression in Human Insulinomas by Vesterinen, Tiina, Peltola, Elina, Leijon, Helena, Hannula, Päivi, Huhtala, Heini, Mäkinen, Markus J, Nieminen, Lasse, Pirinen, Elina, Rönty, Mikko, Söderström, Mirva, Jaatinen, Pia, Arola, Johanna

    “…Insulinomas are rare functional pancreatic neuroendocrine tumours, which metastasize in 10% of cases. As predicting the prognosis can be challenging, there is…”
    Get full text
    Journal Article
  9. 9

    Prognostic and predictive role of tumour-associated macrophages in HER2 positive breast cancer by Honkanen, Tiia J., Tikkanen, Antti, Karihtala, Peeter, Mäkinen, Markus, Väyrynen, Juha P., Koivunen, Jussi P.

    Published in Scientific reports (29-07-2019)
    “…Disease outcomes of HER2+ breast cancers have dramatically improved after targeted therapies, such as trastuzumab became available. The main mechanism of…”
    Get full text
    Journal Article
  10. 10

    Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma by Stefanius, Karoliina, Ylitalo, Laura, Tuomisto, Anne, Kuivila, Rami, Kantola, Tiina, Sirniö, Päivi, Karttunen, Tuomo J, Mäkinen, Markus J

    Published in Histopathology (01-04-2011)
    “…Stefanius K, Ylitalo L, Tuomisto A, Kuivila R, Kantola T, Sirniö P, Karttunen T J & Mäkinen M J
(2011) Histopathology58, 679–692
Frequent mutations of KRAS in…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Divergent expression of bacterial wall sensing Toll-like receptors 2 and 4 in colorectal cancer by Paarnio, Karoliina, Väyrynen, Sara, Klintrup, Kai, Ohtonen, Pasi, Mäkinen, Markus J, Mäkelä, Jyrki, Karttunen, Tuomo J

    Published in World journal of gastroenterology : WJG (14-07-2017)
    “…To characterize the expression of toll-like receptors (TLR) 2 and 4 in colorectal cancer (CRC) and in normal colorectal mucosa. We analysed tissue samples from…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    High Familial Risk in Nodular Lymphocyte-Predominant Hodgkin Lymphoma by SAARINEN, Silva, PUKKALA, Eero, VAHTERISTO, Pia, MÄKINEN, Markus J, FRANSSILA, Kaarle, AALTONEN, Lauri A

    Published in Journal of clinical oncology (01-03-2013)
    “…Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is one of the two established Hodgkin lymphoma (HL) subtypes. The risk factors of NLPHL are largely…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Ectopic crypt foci in conventional and serrated colorectal polyps by Väyrynen, Sara A, Väyrynen, Juha P, Klintrup, Kai, Mäkelä, Jyrki, Tuomisto, Anne, Mäkinen, Markus J

    Published in Journal of clinical pathology (01-12-2016)
    “…Despite almost pathognomonic status of ectopic crypt foci (ECF) in the diagnosis of traditional serrated adenoma (TSA), there are few systematic studies on…”
    Get more information
    Journal Article
  20. 20

    KRAS and BRAF mutations induce anoikis resistance and characteristic 3D phenotypes in Caco‑2 cells by Patankar, Madhura, Eskelinen, Sinikka, Tuomisto, Anne, Mäkinen, Markus J, Karttunen, Tuomo J

    Published in Molecular medicine reports (01-11-2019)
    “…In a number of types of cancer, anoikis, a form of apoptosis induced by loss of extracellular matrix (ECM) attachment, is disturbed. Anoikis resistance is…”
    Get full text
    Journal Article